Lyka Labs (BOM:500259) PB Ratio : 5.16 (As of Jun. 09, 2024)

View and export this data going back to 1992. Start your Free Trial

What is Lyka Labs PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-06-09), Lyka Labs's share price is ₹106.20. Lyka Labs's Book Value per Share for the quarter that ended in Mar. 2024 was ₹20.60. Hence, Lyka Labs's PB Ratio of today is 5.16.

Good Sign:

Lyka Labs Ltd stock PB Ratio (=5.16) is close to 3-year low of 5.16

The historical rank and industry rank for Lyka Labs's PB Ratio or its related term are showing as below:

BOM:500259' s PB Ratio Range Over the Past 10 Years
Min: 0.32 Med: 3.24 Max: 41.27
Current: 5.16

During the past 13 years, Lyka Labs's highest PB Ratio was 41.27. The lowest was 0.32. And the median was 3.24.

BOM:500259's PB Ratio is ranked worse than
79.69% of 1305 companies
in the Biotechnology industry
Industry Median: 2.47 vs BOM:500259: 5.16

During the past 12 months, Lyka Labs's average Book Value Per Share Growth Rate was 39.10% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Lyka Labs was -8.50% per year. The lowest was -32.80% per year. And the median was -18.00% per year.

Back to Basics: PB Ratio

Lyka Labs PB Ratio Historical Data

The historical data trend for Lyka Labs's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lyka Labs PB Ratio Chart

Lyka Labs Annual Data

Trend

Jun14

Jun15

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

PB Ratio

Get a 7-Day Free Trial

29.17

7.07

5.14

Lyka Labs Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
PB Ratio	Get a 7-Day Free Trial															7.07	-	5.62	-	5.14

Competitive Comparison of Lyka Labs's PB Ratio

For the Biotechnology subindustry, Lyka Labs's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lyka Labs's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lyka Labs's PB Ratio distribution charts can be found below:

* The bar in red indicates where Lyka Labs's PB Ratio falls into.

Lyka Labs PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Lyka Labs's PB Ratio for today is calculated as follows:

PB Ratio	=	Share Price	/	Book Value per Share (Q: Mar. 2024)
	=	106.20	/	20.597
	=	5.16

It can also be calculated from the numbers for the whole company:

PB Ratio

Market Cap

(Total Stockholders Equity

Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Lyka Labs (BOM:500259) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

Lyka Labs PB Ratio Related Terms

Thank you for viewing the detailed overview of Lyka Labs's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Lyka Labs (BOM:500259) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lyka Labs Ltd (BOM:500259) » Definitions » PB Ratio

Comparable Companies

Traded in Other Exchanges

LYKALABS:India

Address

30, Forjett Street, Near Bhatia Hospital, Ground floor, Spencer Building (Block B & C), Grant Road (West), Mumbai, MH, IND, 400036

Website

http://www.lykalabs.com

Lyka Labs Ltd is an Indian biotechnology company. It mainly engages in the development of specialized formulations. The Company is engaged in only one segment viz. pharmaceuticals. The Company has presence in Domestic as well as International markets. The commercialized formulations of the company consist of hair care, anti-aging, acne management, skin lightening, face washes, sunscreens, facial scrubs, and others. It has developed a varied drug delivery system for topical steroids, painkillers, anti-fungal, and other emollients as well as liquid injectables, lyophilized injectables in the anti-bacterial, antifungal segment. The company also manufactures proton pump inhibitors, antibiotics, antifungals, steroids, etc. The majority of the company's revenue comes from India.

Lyka Labs (BOM:500259) Headlines

No Headlines